Status:

RECRUITING

Incidence and Risks Factors of CMV Reactivation in Patients Receiving of CAR-T Cells for Acute Leukemia and Lymphoma Relapse, a Cohort Study Analysis

Lead Sponsor:

Assistance Publique - Hôpitaux de Paris

Conditions:

Cytomegalovirus Infections

Acute Leukemia

Eligibility:

All Genders

1-100 years

Brief Summary

Letermovir is approved for the primary prevention of Cytomegalovirus (CMV) reactivation and infection in hematopoietic stem cell transplant recipients. Letermovir may be beneficial in other clinical p...

Eligibility Criteria

Inclusion

  • Common inclusion criteria :
  • Paediatric (1 to 18 years old) receiving CART-T cells treatment for refractory acute leukemia or B-cell lymphoma
  • Adult receiving CART-T cells treatment for refractory acute leukemia or B-cell lymphoma
  • CMV seropositive patients
  • Inclusion criteria : retrospective part
  • Provide written non-opposition from the patient signed by investigator
  • If the patient is a minor, provide written non-opposition from both parents and child (if age appropriate to collect their non-objection) or child and the legal representative in case only one parent is alive, signed by investigator
  • Inclusion criteria : prospective part
  • Provide written consent form signed by patient and investigator
  • If the patient is a minor, provide written consent form signed by investigator and both parents or signed by investigator and the legal representative in case only one parent is alive
  • Exclusion Criteria:
  • CMV seronegative patients
  • Lack of affiliation to a social security scheme (as a beneficiary or assignee)
  • Patients under guardianship / curatorship
  • Patient under AME (state medical aid)

Exclusion

    Key Trial Info

    Start Date :

    April 17 2024

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ESTIMATED

    End Date :

    April 17 2025

    Estimated Enrollment :

    250 Patients enrolled

    Trial Details

    Trial ID

    NCT06058858

    Start Date

    April 17 2024

    End Date

    April 17 2025

    Last Update

    July 17 2024

    Active Locations (3)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (3 locations)

    1

    Hopital Robert Debré - APHP

    Paris, France

    2

    Hopital Saint Louis - APHP - Service d'hématologie " Unité Adolescents et jeunes adultes "

    Paris, France

    3

    Hopital Saint-Louis - APHP - Service d'éhamotologie - oncologie

    Paris, France